Universal Coverage… “Pharmaceutical Benefit Management” or “Pharmacy Benefit Management” is the set of rules, controls and enforcement tools that define.

Slides:



Advertisements
Similar presentations
Pharmaceutical Policy and Pricing: How are Countries Getting Greater Value? Commonwealth Fund/ Alliance for Health Reform Briefing on Capitol Hill Dr.
Advertisements

What You Wanted to Know About Formularies Emmanuelle Mirsakov Pharm.D. Candidate 2007 USC School Of Pharmacy.
Will this new prescription work with my other medicines? Are there any side effects? What if I miss a dose? Have questions about your medicines?
Pharmacy Services Agreements Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 5/08/06.
The Implications of the New Medicare Prescription Drug Legislation for Health Care Providers Anthony A. Barrueta Senior Counsel, Government Relations Kaiser.
The critical role of Evolving Information Systems and the need for Standardised Coding.
Portugal Economic Evaluation Applied to Decision Making Isaura Vieira INFARMED, I.P. – National Authority for Medicines and Health Products I Pan-American.
Chapter 7 The Business of Community Pharmacy. MANAGING COMPUTER SYSTEMS Parts of a Computer System: Some of the more important parts of a typical computer.
Delmar Learning Copyright © 2003 Delmar Learning, a Thomson Learning company Chapter 6 Health Care Economics.
The Health Care Delivery System: Managed Care Part Two Craig A. Pedersen, R.Ph., Ph.D. Department of Pharmaceutical and Administrative Sciences School.
Benefits Update Health Care Reform July Stanford University Confidential – Do Not Reproduce Page 1  Plans must provide coverage for children to.
MEDICARE: PAST, PRESENT AND FUTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Retail Prescription Drug Spending In The National Health Accounts Health Affairs, Vol 23, Issue 1, Copyright © 2004 by Project HOPE
Chapter 7 The Business of Community Pharmacy. Chapter 7 The Business of Community Pharmacy.
Deciphering Medicare Part D Susan Miller, Patient Education Douglas A. Magenheim, MD, MBA, FACP.
1 Managed Health Care Pricing for Provider Arrangements Presented by Vanessa Olson Seminar on Health and Managed Care October 18, 1999.
1 Health Insurance Briefing 22 July 2010 CHANGES IN THE HEALTH INSURANCE PROGRAMMES
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
“Generic Medicines in the Taiwanese and German Legal Systems” 03 June 2011 in Taipei, Taiwan Role of Generics in the German Health Care System Financial.
March Sliding Fee Scales, Patients Cap on Charges Eli Camhi, MSSW – Tom Hickey -
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
HEALTHCARE FINANCING REFORM IN AUSTRALIA International Hospital Federation Congress 2001 Pre Congress Health Summit, Hong Kong 14 May 2001 Presented by.
Healthcare Reforms and Pharmaceuticals Lessons from Turkey Prof. Dr. Mehtap Tatar Hacettepe University Faculty of Economics and Administrative Sciences.
Health care system In Thailand.
PNHP Plan Principles Access to comprehensive health care is a human right The right to chose and change one’s physician is fundamental Pursuit of corporate.
Health Finance Reforms in Southern Europe: Lessons from Croatia European Health Forum September 27, 2002 Akiko Maeda, Lead Health Specialist The World.
State Strategies: Expanding Prescription Drug Access Dee Mahan Families USA November 1, 2002.
Pharmaceutical benefit management under health insurance – common issues in emerging economies Zagreb, January 19, 2010 Andreas Seiter World Bank.
State Opportunities under the 340B Drug Discount Program by Bill von Oehsen Counsel Public Hospital Pharmacy Coalition Phone:
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
Pharmaceutical system strengthening – Is there a need for a new paradigm? Andreas Seiter The World Bank ICIUM 2011, Antalya 1.
© 2009 Cengage Learning. All Rights Reserved. Medicare.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
FINANCIAL ISSUES CHAPTER 14. CHAPTER OUTLINE Financial Issues Third-Party Programs – private health insurance – managed care programs – public health.
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
Avalere Health LLC | The intersection of business strategy and public policy Overview of Coverage of Drugs Under the Medicaid Medical Benefit June 4, 2008.
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
Drug Policy Experience of Visegrad Group countries, Warszava Oct 29-30, 2007 Monitoring of doctor´s prescription in the Czech Republic Tomas Sechser Daniela.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
Seniors’ Health Program Kevin Ring, Human Resources.
The Patient Protection and Affordable Care Act. The Affordable Care Act Signed into law on March 23, 2010 Implemented incrementally You can keep your.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Exhibit 8.1 Number of Medicare Beneficiaries, Fiscal Years (a) Copyright 2011 by the Foundation of the American College of Healthcare Executives.
Health Insurance Plans 2.4 Cost is a major concern Health care is over 15% of the gross national product Without insurance the cost of an illness can become.
Copyright © 2006 Elsevier, Inc. All rights reserved Chapter 16 Economics of the Health Care System.
1 Access to medicines for patients with mental health diseases within State Guarantee Benefit Programme in Talas and Batken regions of KG Makenbaeva B.
More Security and Stability If You Have Health Insurance, the Obama Plan: Ends discrimination against people with pre-existing conditions. Limits premium.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
Pharmacy Benefit Management (PBM) 101
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
Financial Issues Chapter 14. Financial Issues Financial issues have a substantial influence on health care and pharmacy practice. In 1985 the average.
Chapter 4 The Legal and Regulatory Environment of Health Care.
2016 LEGISLATIVE SESSION BRIAN COLBY MISSOURI HEALTH ADVOCACY ALLIANCE.
The Pharmacy Technician 4E
Why 30-Day Pharmacy Payment Cycles Lower Costs and Prevent Fraud
Pharmacy as a Business Explain third-party administration.
Audit Results May 2016 Stourport Health Centre
National Medicare Prescription Drug Congress
Comments from France on the 2013 Commonwealth Fund Survey
Budget Proposals Have Myriad Effects on the Industry
Abstract Impact of the National Healthcare Reform on Prescribing Patterns of Promotional Targeted Drugs among Thai Physicians Layton MR*, Chadbunchachai.
Will PBMs Participate in the New Medicare Prescription Drug Program
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Pharmacy Benefit Manager
Presentation transcript:

Universal Coverage… “Pharmaceutical Benefit Management” or “Pharmacy Benefit Management” is the set of rules, controls and enforcement tools that define how eligible beneficiaries can obtain third party payment for prescription medicines under a public budget or insurance funded healthcare program Typically includes coverage for a range of pharmaceutical products: 1 Andreas Seiter and Timothy Johnston Health, Nutrition, and Population Global Practice The World Bank

Drug budget overruns are the norm… 2

Define rules and develop tools upfront… Restrictive – stay on the safe side; later more benefits can be added Enforceable – have all management tools in place before benefit is implemented 3

Using data to adjust rules and inform negotiations 4 Expenditure tracking against budget Performance against agreed goals for rational use Identifying patterns of abuse, overuse Flagging potential fraud Measuring cost- effectiveness of prescribing Enforcement of price- volume agreements (Examples)

Setting parameters for a pharmaceutical benefit 5 Reimbursement list: which medicines are covered Patient eligibility (sub- population, condition, age, gender etc.) Reimbursement rates, prices, discounts, budget caps etc. Patient co-payment; exemptions, limits Compensation for distributor, pharmacist; substitution rights Assessment and decision making on inclusion of new technologies Case management for high-cost patients Negotiation strategies for deals with industry Static components (although regularly updated) Dynamic processes